Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
47.19 USD | -0.67% | -3.58% | +339.61% |
May. 08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
May. 08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- Official Publications